The impact of the COVID-19 pandemic on cardiovascular disease prevention and management
| العنوان: | The impact of the COVID-19 pandemic on cardiovascular disease prevention and management |
|---|---|
| المؤلفون: | Dale, Caroline E, Takhar, Rohan, Carragher, Raymond, Katsoulis, Michail, Torabi, Fatemeh, Duffield, Stephen, Kent, Seamus, Mueller, Tanja, Kurdi, Amanj, Le Anh, Thu Nguyen, McTaggart, Stuart, Abbasizanjani, Hoda, Hollings, Sam, Scourfield, Andrew, Lyons, Ronan A, Griffiths, Rowena, Lyons, Jane, Davies, Gareth, Harris, Daniel, Handy, Alex, Mizani, Mehrdad A, Tomlinson, Christopher, Thygesen, Johan H, Ashworth, Mark, Denaxas, Spiros, Banerjee, Amitava, Sterne, Jonathan A C, Brown, Paul, Bullard, Ian, Priedon, Rouven, Mamas, Mamas A, Slee, Ann, Lorgelly, Paula, Pirmohamed, Munir, Khunti, Kamlesh, Morris, Andrew D, Sudlow, Cathie, Akbari, Ashley, Bennie, Marion, Sattar, Naveed, Sofat, Reecha |
| المصدر: | Dale, C E, Takhar, R, Carragher, R, Katsoulis, M, Torabi, F, Duffield, S, Kent, S, Mueller, T, Kurdi, A, Le Anh, T N, McTaggart, S, Abbasizanjani, H, Hollings, S, Scourfield, A, Lyons, R A, Griffiths, R, Lyons, J, Davies, G, Harris, D, Handy, A, Mizani, M A, Tomlinson, C, Thygesen, J H, Ashworth, M, Denaxas, S, Banerjee, A, Sterne, J A C, Brown, P, Bullard, I, Priedon, R, Mamas, M A, Slee, A, Lorgelly, P, Pirmohamed, M, Khunti, K, Morris, A D, Sudlow, C, Akbari, A, Bennie, M, Sattar, N & Sofat, R 2023, ' The impact of the COVID-19 pandemic on cardiovascular disease prevention and management ', Nature Medicine, vol. 29, no. 1, pp. 219-225 . https://doi.org/10.1038/s41591-022-02158-7 Dale, C E, Takhar, R, Carragher, R, Katsoulis, M, Torabi, F, Duffield, S, Kent, S, Mueller, T, Ahmad, A, McTaggart, S, Abbasizanjani, H, Hollings, S, Scourfield, A, Lyons, R A, Griffiths, R, Lyons, J, Davies, G, Harris, D, Handy, A, Mizani, M, Tomlinson, C, Thygesen, J H, Ashworth, M, Denaxas, S, Banerjee, A, Sterne, J A C, Brown, P, Bullard, I, Priedon, R, Mamas, M, Slee, A, Lorgelly, P, Pirmohamed, M, Khunti, K, Morris, A, Sudlow, C, Akbari, A, Bennie, M, Sattar, N & Sofat, R 2023, ' The impact of the COVID-19 pandemic on cardiovascular disease prevention and management ', Nature Medicine, vol. 29, no. 1, pp. 219–225 . https://doi.org/10.1038/s41591-022-02158-7 |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Cardiovascular Diseases - epidemiology - prevention & control - diagnosis, Pandemics - prevention & control, SDG 3 - Good Health and Well-being, Risk Factors, Hypertension - complications - drug therapy - epidemiology, COVID-19 - epidemiology, Humans, General Medicine, Diabetes Mellitus, Type 2 - complications - drug therapy - epidemiology, General Biochemistry, Genetics and Molecular Biology |
| الوصف: | How the Coronavirus Disease 2019 (COVID-19) pandemic has affected prevention and management of cardiovascular disease (CVD) is not fully understood. In this study, we used medication data as a proxy for CVD management using routinely collected, de-identified, individual-level data comprising 1.32 billion records of community-dispensed CVD medications from England, Scotland and Wales between April 2018 and July 2021. Here we describe monthly counts of prevalent and incident medications dispensed, as well as percentage changes compared to the previous year, for several CVD-related indications, focusing on hypertension, hypercholesterolemia and diabetes. We observed a decline in the dispensing of antihypertensive medications between March 2020 and July 2021, with 491,306 fewer individuals initiating treatment than expected. This decline was predicted to result in 13,662 additional CVD events, including 2,281 cases of myocardial infarction and 3,474 cases of stroke, should individuals remain untreated over their lifecourse. Incident use of lipid-lowering medications decreased by 16,744 patients per month during the first half of 2021 as compared to 2019. By contrast, incident use of medications to treat type 2 diabetes mellitus, other than insulin, increased by approximately 623 patients per month for the same time period. In light of these results, methods to identify and treat individuals who have missed treatment for CVD risk factors and remain undiagnosed are urgently required to avoid large numbers of excess future CVD events, an indirect impact of the COVID-19 pandemic. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758f0b3dffefa8dfc5ac4e4813b9a77f https://pure.qub.ac.uk/en/publications/3a8747aa-c4de-4804-b279-78c7fb2cc392 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....758f0b3dffefa8dfc5ac4e4813b9a77f |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |